Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3851525 | American Journal of Kidney Diseases | 2008 | 11 Pages |
Abstract
The clinical course of patients with chronic kidney disease stage 4 is variable. Targeted therapy aimed at modifiable risk factors needs to be evaluated to determine benefits of this approach.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Adeera MD, FRCPC, Ognjenka MSc, Monica MD, FRCPC, Lee MSc,